FDA revokes authorization for key anti-COVID drug, a blow for vulnerable Americans

  • 📰 latimes
  • ⏱ Reading Time:
  • 23 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 82%

United States Headlines News

United States Latest News,United States Headlines

Evusheld was designed to protect immunocompromised people from serious cases of COVID-19, but the latest Omicron variants have rendered the drug useless

, a medication that was once a valuable tool for preventing patients with weakened immune systems from becoming severely ill with COVID-19.the biological drug should no longer be used.

— 7.2 million adults — is thought to have immune deficiencies that put them at risk of becoming severely ill or dying if they are infected with the pandemic virus., an infectious disease doctor at Massachusetts General Hospital who cares for people with impaired immunity. For her patients, she said, “it was kind of like being told the seat belts in your car won’t work anymore, and we’re not going to be able to replace them with anything.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

It’s time we invested in a scalable solution that targets mucosal immunity that could prevent infection & transmission! It would be easy, cheap, safe & more effective to ship & deliver billions of Vaxart Covid19 💊 vaccines & boosters to everyone.

Revoking authorization isn’t “the blow.” Read your own story.

Zero credibility. FDA is a corrupt business, only.

Your interpretation of vulnerable Americans are those who would rather get severe life threatening side effects from medicine rather than deal with flu like symptoms.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 11. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

FDA halts authorization of Evusheld, citing medication insufficient against viral COVID-19 variantsSeveral antibody therapies used against Covid-19 earlier in the pandemic are no longer available because the virus has evolved and they are no longer effective.
Source: ABC7Chicago - 🏆 284. / 63 Read more »

FDA halts authorization of Evusheld, citing medication insufficient against viral COVID-19 variantsSeveral antibody therapies used against Covid-19 earlier in the pandemic are no longer available because the virus has evolved and they are no longer effective.
Source: abc7newsbayarea - 🏆 529. / 51 Read more »

FDA halts authorization of Evusheld, citing medication insufficient against viral COVID-19 variantsSeveral antibody therapies used against Covid-19 earlier in the pandemic are no longer available because the virus has evolved and they are no longer effective.
Source: ABC7NY - 🏆 592. / 51 Read more »

FDA halts authorization of Evusheld, citing medication insufficient against viral COVID-19 variantsSeveral antibody therapies used against Covid-19 earlier in the pandemic are no longer available because the virus has evolved and they are no longer effective. Pfizer caught with their pants down again projectveritas Well then how can antibodies produced by the body after vaccination be any more effective The vax ain’t doing shit either so why is that still being pushed?
Source: 6abc - 🏆 250. / 63 Read more »

U.S. FDA pulls authorization for AstraZeneca's COVID-19 treatment EvusheldThe U.S. health regulator has withdrawn emergency-use authorization for AstraZeneca's COVID-19 antibody cocktail Evusheld as the treatment is not expected to neutralize the currently dominant XBB.1.5 subvariant of Omicron. they prob couldnt afford FDA approval fee
Source: Reuters - 🏆 2. / 97 Read more »

FDA withdraws Covid antibody treatment Evusheld because it's not effective against 93% of subvariantsMany take Evusheld as an additional layer of protection because the vaccines do not trigger a strong immune response for them. Cue….3,2, 1 Sure. Says Pfi$$er. 🤡
Source: CNBC - 🏆 12. / 72 Read more »